tweenvest

MAIA Biotechnology, Inc. (NYSEAM: MAIA)

Health Care · Biotechnology · US

$1.11

-2.63% today · +12.2% 1Y

Public summary
A free snapshot of MAIA Biotechnology, Inc., with figures as of Nov 22, 2026. The full analysis is in the app.Open in the app

MAIA Biotechnology, Inc. (NYSEAM: MAIA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $68.54M and employs 13 people.

Over the last twelve months the share price has gained 12.2%, trading between 0.89 and 3.19.

Tweenvest scores MAIA Biotechnology, Inc. across four factors: quality 42/100, value 39/100. Its strongest factor is quality.

MAIA price history

Nov 28, 2025 · 1.18Weekly closes 1.00 – 2.56Nov 20, 2026 · 1.11

Key figures

Market cap
$68.54M
Revenue (TTM)
—
P/E
-2.73
EPS
-0.49
Dividend yield
—
Beta (5Y)
0.30
52-week high
$3.19
52-week low
$0.89
Avg volume (3M)
—
Shares outstanding
61.75M
Employees
13
Next earnings
—

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.

ISIN
US5526411021
Founded
2018
Listed since
Jul 28, 2022
Exchange
NYSE American LLC
Currency
USD
CompanyMarket capPriceDay
Coya Therapeutics, Inc.NasdaqCM: COYA$70.84M$3.02+0.67%
BIOTON S.A.WSE: BIO$70.64Mzł3.34-2.20%
Cell Biotech Co., Ltd.KOSDAQ: A049960$69.69M₩13,660.00-0.87%
Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP$69.55M$3.38-0.44%
BioPorto A/SCPSE: BIOPOR$68.38MDkr0.94-1.05%
Great Novel Therapeutics Biotech & MedicalsTPEX: 7427$68.34MNT$52.50-4.72%
BIONET Therapeutics Corp.TPEX: 7808$68.06MNT$32.00-4.90%
Artgen Biotech PJSCMISX: ISKJ$68.01MRUB59.54+1.43%

Browse every Biotechnology company →